Kontafarma China Holdings Limited

SEHK:1312 주식 보고서

시가총액: HK$184.4m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Kontafarma China Holdings 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Feifei Wang

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간less than a year
이사회 평균 재임 기간less than a year

최근 관리 업데이트

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

May 24
There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Dec 28
Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Sep 01
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Dec 29
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Sep 15
Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Apr 20
Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Nov 04
Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

Feb 18
Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

Dec 07
These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

CEO

Feifei Wang

less than a year

테뉴어

Mr. Feifei Wang is Executive Chairman & President of Kontafarma China Holdings Limited from June 7, 2024.


리더십 팀

이름위치테뉴어보상소유권
Feifei Wang
Executive Chairman & Presidentless than a year데이터 없음데이터 없음
Zixiu Guo
Financial Controller & Executive Directorless than a year데이터 없음데이터 없음
Jie Zhang
Chief Operating Officer3.8yrs데이터 없음데이터 없음
Linna Qiao
VP & Executive Directorless than a year데이터 없음데이터 없음
Jiankun Liu
Executive Directorless than a year데이터 없음데이터 없음
Man Wai Si Tou
VP & Company Secretary9.7yrs데이터 없음데이터 없음

0.08yrs

평균 재임 기간

경험이 풍부한 관리: 1312 의 관리팀은 경험 (평균 재직 기간 0 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Feifei Wang
Executive Chairman & Presidentless than a year데이터 없음데이터 없음
Zixiu Guo
Financial Controller & Executive Directorless than a year데이터 없음데이터 없음
Linna Qiao
VP & Executive Directorless than a year데이터 없음데이터 없음
Jiankun Liu
Executive Directorless than a year데이터 없음데이터 없음
Lai Wah Tang
Independent Non-Executive Directorless than a year데이터 없음데이터 없음
Yu Huang
Non-Executive Director10.3yrsHK$1.67m데이터 없음
Ho Ming Ho
Independent Non-Executive Directorless than a year데이터 없음데이터 없음
Xiaomin Yao
Independent Non-Executive Directorless than a year데이터 없음데이터 없음

0.08yrs

평균 재임 기간

57.5yo

평균 연령

경험이 풍부한 이사회: 1312 의 이사회경험(평균 재직 기간 0 년)으로 간주되지 않으므로 새 이사회가 필요합니다.